Bladder cancer is an international public health problem affecting millions of people in both developed and underdeveloped nations. This major urologic malignancy was one of the first cancers to be linked to occupational and environmental exposure to carcinogens. Bladder cancer is the 5th most common cancer of American men and the 8th most common c
This book presents state-of-the-art diagnoses and treatments available for bladder cancer that has metastasised into the body.
However, HAL (marketed as Hexvix/Cyview by Photocure, Norway) is the only agent approved in both the United States (FDA approved in 2010) and Europe (2005), so we will center our discussion on this formulation. mucosal folds [17], ...
McInnes MD, Siemens DR, Mackillop WJ, Peng Y, Wei 132 16 A Systematic Review on the Staging Conundrum in Bladder Cancer 16.1.9 Grey Literature Related to Systematic Review 16.1.10 Systematic Review Conclusion References.
This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted.
Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient.
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
This book covers the latest advances in non-muscle invasive bladder cancer care.
This book aims to bring together the current research and discussions surrounding bladder cancer management.
This book provides a comprehensive overview of contemporary evidence-based management of urothelial carcinoma.
Insightful and evidenced-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art ...